These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 453775)

  • 21. [Prazosin in moderate or severe essential arterial hypertension not controlled with chlorthalidone. A multicenter study].
    Saldanha RV; Macruz R; Santana PC; de Lima JJ; Zalc S; Pileggi F
    Arq Bras Cardiol; 1983 Jun; 40(6):433-8. PubMed ID: 6667153
    [No Abstract]   [Full Text] [Related]  

  • 22. [The results of the comparative study of nadolol, propranolol, prazosin and hydrochlorothiazide in patients with arterial hypertension in a 12-month stepped-plan treatment (cooperative research). The Working Group of the Cooperative Program to Study New Preparations in the Prevention of Arterial Hypertension. I. The research protocol and results of monotherapy].
    Metelitsa VI; Filatova NP
    Ter Arkh; 1991; 63(8):30-4. PubMed ID: 1792612
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prazosin in hypertension: a double-blind evaluation with methyldopa and placebo.
    Mroczek WJ; Fotiu S; Davidov ME; Finnerty FA
    Curr Ther Res Clin Exp; 1974 Aug; 16(8):769-77. PubMed ID: 4217243
    [No Abstract]   [Full Text] [Related]  

  • 24. Comparative study with prazosin, methyldopa and polythiazide in arterial hypertension.
    Marinković M; Vrhovac B; Kuzmanić D; Radonić M
    Int J Clin Pharmacol Biopharm; 1979 Jan; 17(1):38-47. PubMed ID: 367977
    [No Abstract]   [Full Text] [Related]  

  • 25. A phase II study of prazosin hydrochloride in hypertensive subjects.
    Paul RR; Sharma PL; Wahi PL
    Int J Clin Pharmacol Biopharm; 1976 Dec; 14(4):271-4. PubMed ID: 794002
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of a new antihypertensive agent ketanserin versus methyldopa in the treatment of essential hypertension in older patients: an international multicenter trial.
    Zin C; Copertari P; Landi E; San Martin C; Lopes M; Feruglio F; Alcocer L
    J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S113-8. PubMed ID: 2446057
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prazosin in the treatment of hypertension.
    Adriaensen H; Vryens R
    Practitioner; 1975 Feb; 214(1280):268-73. PubMed ID: 1096120
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prazosin in hypertension with heart failure.
    Antani JA
    J Cardiovasc Pharmacol; 1979; 1(6 Suppl):S56-62. PubMed ID: 94640
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of the efficacy and safety of enalapril plus hydrochlorothiazide plus methyldopa vs standard triple therapy in the treatment of moderate to severe hypertension: results from a multicentre study.
    Leonetti G; Cuspidi C; Sampieri L; Ambrosioni E; Malini PL; Pessina A; Semplicini A; Cinotti G; Morabito S; Rappelli A
    J Hum Hypertens; 1990 Feb; 4(1):5-11. PubMed ID: 2189027
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term antihypertensive therapy with prazosin plus a diuretic.
    Okun R; Maxwell M
    J Cardiovasc Pharmacol; 1979; 1(6 Suppl):S21-7. PubMed ID: 94636
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prazosin in hypertension with and without methyldopa.
    Kochar MS; Zeller JR; Itskovitz HD
    Clin Pharmacol Ther; 1979 Feb; 25(2):143-8. PubMed ID: 365428
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The clinical evaluation of prazosin, a new antihypertensive agent.
    Pitts NE
    Postgrad Med; 1975 Nov; Spec No():117-27. PubMed ID: 1105484
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential blood pressure responses to intracisternal clonidine, alpha-methyldopa, and 6-hydroxydopamine in conscious normotensive and spontaneously hypertensive rats.
    Head GA; de Jong W
    J Cardiovasc Pharmacol; 1986; 8(4):735-42. PubMed ID: 2427812
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypertension in older patients: what drugs to use and when.
    Caris TN
    Geriatrics; 1982 Mar; 37(3):38-43. PubMed ID: 7067974
    [No Abstract]   [Full Text] [Related]  

  • 35. Comparative antihypertensive and endocrinologic effects of clonidine and prazosin in patients with essential hypertension.
    Hubbell FA; Weber MA; Drayer JI; Rose DE
    South Med J; 1984 Oct; 77(10):1264-8. PubMed ID: 6385278
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fixed ratio combination of propranolol and bendrofluazide in the treatment of hypertension.
    Pandhi P; Sharma BK; Sharma PL; Wahi PL
    Int J Clin Pharmacol Ther Toxicol; 1985 Feb; 23(2):92-4. PubMed ID: 3886568
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of prazosin in management of hypertension in patients with chronic renal failure and in renal transplant recipients.
    Curtis JR; Bateman FJ
    Br Med J; 1975 Nov; 4(5994):432-4. PubMed ID: 811312
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiovascular response to isometric stress (handgrip) in patients with essential hypertension before and after antihypertensive therapy with propranolol or alpha methyldopa.
    Baldwa VS; Gupta BS; Chittora MD
    Indian Heart J; 1983; 35(6):333-6. PubMed ID: 6667950
    [No Abstract]   [Full Text] [Related]  

  • 39. Prazosin in the treatment of hypertension: a preliminary study.
    Seedat YK; North-Coombes D; Rampono JG
    S Afr Med J; 1975 Oct; 49(42):1741-3. PubMed ID: 1188529
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Response to a second single antihypertensive agent used as monotherapy for hypertension after failure of the initial drug. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents.
    Materson BJ; Reda DJ; Preston RA; Cushman WC; Massie BM; Freis ED; Kochar MS; Hamburger RJ; Fye C; Lakshman R
    Arch Intern Med; 1995 Sep; 155(16):1757-62. PubMed ID: 7654109
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.